Información del artículo
El Texto completo está disponible en PDF
References
[1.]
Ficha técnica de TAXOTERE® 80 mg. Grupo Sanofi Aventis. Julio de 2006. Available from: http://www.seom.org/seomcms/images/stories/recursos/sociosyprofs/documentacion/vademecum/2006/sanofiAventis/taxotere_20_jul06.pdf
[2.]
A.M. Minisini, A. Tosti, A.F. Sobrero, M. Mansutti, B.M. Piraccini, C. Sacco, et al.
Taxane-induced nail changes: incidence, clinical presentation, outcome.
Ann Oncol, 14 (2003), pp. 333-337
[3.]
G.C. Zimmerman, J.H. Keeling, H.A. Burris, G. Cook, R. Irvin, J. Kuhn, et al.
Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent.
Arch Dermatol, 131 (1995), pp. 202-206
[4.]
K. Pavithran, D.C. Doval.
Nail changes due to docetaxel.
Br J Dermatol, 146 (2002), pp. 709-710
[5.]
O. Correia, C. Azevedo, E. Pinto Ferreira, F. Braga Cruz, J. Polonia.
Nail changes secondary to docetaxel (Taxotere).
Dermatology, 198 (1999), pp. 288-290
[6.]
J. Hong, S.H. Park, S.J. Choi, S.H. Lee, K.C. Lee, J.I. Lee, et al.
Nail toxicity after treatment with docetaxel: a prospective analysis in patients with advanced non-small cell lung cancer.
Jpn J Clin Oncol, 37 (2007), pp. 424-428
[7.]
L. Palacio, V. García Patos, A. Virós, R. Bartralot, J. Mollet, A. Medina, et al.
Síndrome esclerodermiforme por paclitaxel.
Actas Dermosifiliogr, 95 (2004), pp. 504-507
[8.]
M. Katoh, M. Kadota, Y. Nishimura.
A case of docetaxelinduced erythrodysesthesia.
J Dermatol, 31 (2004), pp. 403-406
[9.]
J. Rodríguez-Lozano, M. Almagro Sánchez, E. Fonseca Capdevila.
Toxicodermia por taxoles.
Piel, 22 (2007), pp. 13-17
[10.]
B. Tallon, S. Lamb.
Flagellate erythema induced by docetaxel.
Clin Exp Dermatol, 33 (2008), pp. 276-277
Copyright © 2009. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
